Table 1.
Characteristics of study participants.
| Characteristics |
STEMI patients (n = 52) |
Controls (n = 59) |
P-Value |
|---|---|---|---|
| Male % | 66.6 | 56.3 | 0.08 |
| Age, yr (mean ± SEM) | 65.2 ± 2.08 | 60.2 ± 1.49 | 0.06 |
| Body mass index (BMI) (mean ± SEM) | 25.8 ± 1.14 | 30.2 ± 1.05 | 0.01* |
| LVEF % | 62% | – | |
| Time (min), onset of chest pain to reperfusion (Median) | 150 (52–738) | NA | |
| LAD Infarct (%) | 41.6 | NA | |
| RCA Infarct (%) | 50 | NA | |
| Circumflex Infarct (%) | 8 | NA | |
| Peak CK (Median) (units/L) | 1,105 (141–10,655) | NA | |
| Peak Tnt (Median) (ng/L) | 1,093 (1–10,000) | NA | |
| Co-morbidity (%) | |||
| Type 2 diabetes mellitus | 20.8 | 14.5 | 0.4 |
| Smoker | 12.7 | 18.7 | 0.3 |
| Hypertension | 41.6 | 48.1 | 0.5 |
| Dyslipidemia | 41.6 | 25.9 | 0.08 |
| Lipids | |||
| TG (mmol/l) | 1.7 ± 1.4 | – | |
| HDL (mmol/l) | 1.2 ± 0.4 | – | |
| LDL (mmol/l) | 2.8 ± 0.9 | – | |
| TC (mmol/l) | 4.2 ± 1.2 | – | |
| Medications at baseline (%) | |||
| ACEI/ARB | 20.8 | 21.8 | 0.9 |
| Betablocker | 6.2 | 16.3 | 0.1 |
| Statin | 16.6 | 14.5 | 0.7 |
*
significantly different compared with controls (P < 0.05).